Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Current Leases: 2020-2025

Historic Current Leases for Prestige Consumer Healthcare (PBH) over the last 6 years, with Mar 2025 value amounting to $6.0 million.

  • Prestige Consumer Healthcare's Current Leases rose 136.25% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year increase of 136.25%. This contributed to the annual value of $6.0 million for FY2025, which is 29.82% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Current Leases stood at $6.0 million for FY2025, which was up 29.82% from $4.7 million recorded in FY2024.
  • Prestige Consumer Healthcare's 5-year Current Leases high stood at $6.9 million for FY2023, and its period low was $4.7 million during FY2024.
  • Over the past 3 years, Prestige Consumer Healthcare's median Current Leases value was $6.0 million (recorded in 2025), while the average stood at $5.9 million.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Current Leases plummeted by 32.75% in 2024, and later climbed by 29.82% in 2025.
  • Prestige Consumer Healthcare's Current Leases (Yearly) stood at $5.9 million in 2021, then increased by 8.57% to $6.4 million in 2022, then rose by 8.90% to $6.9 million in 2023, then slumped by 32.75% to $4.7 million in 2024, then climbed by 29.82% to $6.0 million in 2025.